<div id="readability-page-1">10:29 AM EDT, 05/18/2026 (MT Newswires) -- Eli Lilly ( LLY ) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders.The Court vacated and remanded several cases, including voting rights disputes, while rejecting review in multiple pharmaceutical and healthcare-related petitions, reducing the likelihood of near-term Supreme Court intervention in those matters.The Court granted review in one education case while denying dozens of appeals across civil, criminal, regulatory, and healthcare matters, with Justice Sotomayor separately concurring in the denial of certiorari in a sentencing case in which relief had already been granted.Shares of Eli Lilly ( LLY ) were down 2.2% in Monday trading.Price: 985.25, Change: -19.68, Percent Change: -1.96 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

禮來

2 倍做多 LLY ETF - Defiance

納斯達克生物科技指數 ETF - iShares Nasdaq

禮來在被最高法院拒絕的製藥公司中，該法院駁回了與醫療保健和商業案件相關的多項上訴。此決定降低了最高法院在這些問題上立即介入的可能性。消息公佈後，禮來的股價下跌了 2.2%，至 985.25 美元

Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals

fidelity

Invesco Nasdaq Biotechnology ETF

醫療業 ETF - SPDR

醫療業 ETF - Vanguard

醫藥突破 ETF - ALPS

1 倍做空 LLY ETF - Direxion

Defiance Daily Target 2X Short LLY ETF

動態生物技術與基因組 ETF - Invesco

基因改革 ETF - ARK

標普生物技術 ETF - SPDR

美國制藥 ETF - iShares

2 倍做多 LLY ETF - Direxion

標普生物技術 3 倍做多 - Direxion

標普生物技術 3 倍做空 - Direxion

標普全球醫療股指數 ETF - iShares

2 倍做多納斯達克生物技術 ETF - ProShares

生物科技 ETF - VanEck Vectors

紐交所高增長板生物技術指數 ETF - First Trust

禮來公司等申請者在最高法院拒絕多項上訴時被拒絕受理申請